(Applies to: BIPL)
Biopool International to Trade on OTC Bulletin Board
VENTURA, CALIF. (April 19) BUSINESS WIRE -April 19, 1999--Biopool
International Inc. (OTC BB:BIPL) Monday announced that effective this
date, its shares will no longer trade on the Nasdaq's SmallCap Market
because the bid price for its shares has fallen below the $1-per-share
Nasdaq minimum listing maintenance requirement.
The company's stock now immediately qualifies to trade on the OTC
Bulletin Board under the symbol BIPL.
Michael D. Bick, Ph.D., chairman and chief executive officer of
Biopool, commented: "The move to the OTC Bulletin Board in no way
reflects any adverse financial conditions within the company. Indeed,
we meet and exceed all listing requirements for Nasdaq other than the
$1 minimum bid price."
Founded in 1987, Biopool International develops, manufactures and
markets a full range of test kits to assess and diagnose disorders of
blood coagulation, thrombotic risk factors, fibrinolysis, platelet
function and the vascular system, and specialty chemistry controls used
to monitor and measure the presence of drugs of abuse.
The company's product line is sold to hospitals, clinical laboratories,
commercial reference laboratories and research institutions on a
worldwide basis by the company's own sales representatives, as well as
through an extensive network of distributors.
To learn more about Biopool, visit the company's Web site at
biopool.com.
This news release contains forward-looking statements that are based
upon current expectations that involve a number of risks and
uncertainties, including but not limited to technological innovations
of competitors, changes in health-care regulations, litigation claims,
foreign-currency fluctuation, product acceptance or changes in
government regulation of the company's products, as well as other
factors discussed in the company's last report on Form 10-K-SB under
"Risk Factors."
-0- DB/la* JAP/la
CONTACT: Biopool International Inc., Ventura
Michael D. Bick or Carol Hill, 805/654-0643
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY PHARMACEUTICAL Today's News
On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com |
